Acadia Healthcare Company, Inc. ACHC
37.81 USD -0.99 (-2.55%)
At closeNov 12, 2026, 5:24 PM EST
37.81 0.00 0.00%
After hours · Nov 12, 5:24 PM ET
37.32 Day range 39.25
11.43 52-week range 39.70
- YTD
- +166.46%
- 1 year
- +117.17%
- Market cap
- 3.52B
- Revenue (ttm)
- 3.41B
- Profit margin
- -33.07%
- EPS (ttm)
- -12.44
- Shares out
- 92.97M
- Forward P/E
- 18.55
- YTD return
- +166.46%
- 1-year return
- +117.17%
- Volume
- 1.67M
- Avg volume
- 1.80M
- Open
- 38.85
- Previous close
- 38.80
- Day's range
- 37.32 – 39.25
- 52-week range
- 11.43 – 39.70
- Beta
- 0.63
- Analysts
- Buy
- Price target
- 38.79 (+2.6%)
- Earnings date
- Feb 24, 2027
5D +1.57 (+4.22%)
Key statistics
- Enterprise value
- 6.20B
- PEG ratio
- 1.37
- Price / sales
- 1.03
- Price / book
- 1.70
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 5.10%
- Free cash flow
- 32.96M
- Total cash
- 163.31M
- Total debt
- 2.53B
- Return on equity
- -40.48%
- Short % of float
- 32.44%
- 50-day average
- 30.04
- 200-day average
- 26.63
Analyst view
Consensus: buy
Buy
Price target (mean) 38.79 +2.6% upside
Now 37.81
- Target (low)
- 19.00
- Target (mean)
- 38.79
- Target (high)
- 46.00
Ratings (0m) 14 8 buy · 5 hold · 1 sell
- Strong buy2
- Buy6
- Hold5
- Sell0
- Strong sell1
Next earnings
Feb 24, 2027
Expected Feb 24, 2027. Consensus EPS estimate 0.39257.
Financials — quick view
ACHC Revenue — quarterly 895.31M
ACHC Net income — quarterly 34.49M
ACHC EPS — quarterly 0.38
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 24, 2027 | Dec 30, 2026 | 0.38 | — | — | — |
| Nov 4, 2026 | Sep 30, 2026 | 0.4625 | 0.60 | +0.14 | +29.73% |
| Jul 28, 2026 | Jun 30, 2026 | 0.3463 | 0.38 | +0.03 | +9.73% |
| Apr 29, 2026 | Mar 31, 2026 | 0.28 | 0.37 | +0.09 | +32.14% |
| Feb 25, 2026 | Dec 31, 2025 | 0.03 | 0.07 | +0.04 | +133.33% |
| Nov 5, 2025 | Sep 30, 2025 | 0.68 | 0.72 | +0.04 | +5.88% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 6, 2026 | RBC Capital | main | Outperform | Outperform |
| Nov 6, 2026 | Guggenheim | main | Buy | Buy |
| Nov 6, 2026 | Cantor Fitzgerald | main | Neutral | Neutral |
| Nov 5, 2026 | Barclays | main | Equal-Weight | Equal-Weight |
| Sep 23, 2026 | Leerink Partners | main | Market Perform | Market Perform |
| Jul 30, 2026 | Guggenheim | main | Buy | Buy |
About Acadia Healthcare Company, Inc.
Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company owns and operates acute inpatient psychiatric facilities; specialty treatment facilities comprising residential recovery facilities and eating disorder facilities; comprehensive treatment centers; and residential treatment centers, as well as facilities providing outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Country
- United States
- Website
- acadiahealthcare.com
News
What Makes Acadia Healthcare (ACHC) a Strong Momentum Stock: Buy Now? 
Acadia Healthcare Company, Inc. (ACHC) Presents at 2026 UBS Global Healthcare Conference Transcript 
Acadia Healthcare Company, Inc. (ACHC) Q3 2026 Earnings Call Transcript 
RBC Capital Maintains Outperform on Acadia Healthcare Co, Raises Price Target to $41 
Guggenheim Maintains Buy on Acadia Healthcare Co, Raises Price Target to $41 
Is Acadia Healthcare (ACHC) Stock Outpacing Its Medical Peers This Year? 
Acadia Healthcare Company, Inc. (ACHC) Hit a 52 Week High, Can the Run Continue? - Cantor Fitzgerald Maintains Neutral on Acadia Healthcare Co, Raises Price Target to $39
Acadia Healthcare (NASDAQ:ACHC) Hits New 12-Month High on Strong Earnings - Barclays Maintains Equal-Weight on Acadia Healthcare Co, Raises Price Target to $35
Your note
Sign in to keep a note on ACHC — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BERNHARD JASON R. | Director | Stock Award(Grant) | May 5, 2026 | 45,359 |
| BISSELL E PEROT | Director | Stock Award(Grant) | May 5, 2026 | 57,486 |
| DIXON HEATHER BRIANNE | Chief Financial Officer | Stock Award(Grant) | May 4, 2025 | 122,499 |
| FARLEY BRIAN P | Officer | Stock Award(Grant) | Apr 27, 2026 | 144,185 |
| GRIECO WILLIAM F | Director | Stock Award(Grant) | May 5, 2026 | 96,212 |
| HUNTER CHRISTOPHER H | Chief Executive Officer | Stock Award(Grant) | May 4, 2025 | 265,883 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 16.09% | 14,957,168 | 565.53M | Jun 29, 2026 |
| Wellington Management Group, LLP | 6.16% | 5,726,246 | 216.51M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 5.78% | 5,369,461 | 203.02M | Jun 29, 2026 |
| Carronade Capital Management, Lp | 5.12% | 4,762,635 | 180.08M | Jun 29, 2026 |
| Dimensional Fund Advisors LP | 5.05% | 4,698,457 | 177.65M | Sep 29, 2026 |
| FMR, LLC | 5.02% | 4,665,515 | 176.40M | Sep 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 5.96% | 5,542,769 | 209.57M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.99% | 2,779,857 | 105.11M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.62% | 2,436,016 | 92.11M | Sep 29, 2026 |
| American Century ETF Trust-Avantis U.S. Small Cap Value ETF | 2.58% | 2,394,157 | 90.52M | Sep 29, 2026 |
| Fidelity Capital Trust-Fidelity Value Fund | 2.22% | 2,063,300 | 78.01M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.15% | 2,002,253 | 75.71M | Jun 29, 2026 |